March 1, 2022 01:38 PM EST
FDA+

Im­prov­ing can­cer drug re­search: FDA re­works and fi­nal­izes guid­ance doc­u­ments

Zachary Brennan

Senior Editor

To align with Pres­i­dent Biden’s re­newed push around his Can­cer Moon­shot project, the FDA on Tues­day re­leased new guid­ance to com­pa­nies spon­sor­ing on­col­o­gy tri­als and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Vi­a­tris' In­dia-based man­u­fac­tur­ing site blocked from ship­ping 11 gener­ic drugs to US

A service from the Financial Times